Effect of concurrent elemental diet on infliximab treatment for Crohn’s disease
- 16 June 2006
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (7), 1143-1149
- https://doi.org/10.1111/j.1440-1746.2006.04317.x
Abstract
Background: Infliximab and elemental diet (ED) have been shown to be effective in the management of Crohn’s disease. However, few experiences have been reported regarding their combination therapy. The aim of the present study was to investigate the efficacy and safety of infliximab in Japanese patients, the first such study in Asia, as well as the effect of concomitant ED. Methods: One hundred and ten consecutive patients receiving infliximab were followed up to week 16 after the last infusion, and clinical response and primary outcome were collected. A response was defined as a reduction in Harvey–Bradshaw Index for inflammatory disease and closure of fistula in fistulizing disease. Results: Out of 75 inflammatory and 35 fistulizing disease patients, 68 (90.7%) and 25 (71.4%) responded at week 4, and 38 (50.7%) and 14 (40.0%) continued to respond until week 16, respectively. Interestingly, inflammatory disease patients with concurrent ED had a significantly higher response rate at week 16 (68.4%) than those without ED (32.4%, P = 0.0026). The effects of ED were independent of the usage of azathioprine and smoking habit. Conclusions: Infliximab was clinically useful in the treatment of Crohn’s disease in Japanese patients as well as in those in Western countries. The efficacy of concurrent ED was suggestive and should be confirmed in a randomized controlled study.Keywords
This publication has 23 references indexed in Scilit:
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseThe New England Journal of Medicine, 2004
- Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's DiseaseThe New England Journal of Medicine, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentThe New England Journal of Medicine, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseThe New England Journal of Medicine, 1999
- Enteral nutrition for Crohn's disease in JapanDiseases of the Colon & Rectum, 1997
- Supplementary enteral nutrition maintains remission in paediatric Crohn's disease.Gut, 1996
- Defined-Formula Diets versus Steroids in the Treatment of Active Crohn's Disease A Meta-AnalysisScandinavian Journal of Gastroenterology, 1996
- How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta‐Analysis of the Randomized Clinical TrialsJournal of Parenteral and Enteral Nutrition, 1995
- Involvement of capsaicin-sensitive neurons in gastrin release provoked by intragastric administration of bile salts in the ratThe Esophagus, 1995
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980